R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO

P3746692

Titles and Roles

Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Professor, Department of Pharmacology and Chemical Biology
Emory University School of Medicine
Executive Director, Woodruff Industry Sponsored Clinical Trials
Woodruff Health Sciences Center
Vice President, Clinical Research
Woodruff Health Sciences Center
Research Program
Discovery and Developmental Therapeutics

Biography

R. Donald Harvey, PharmD, is a professor in the Department of Hematology and Medical Oncology with a joint appointment in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine. A board-certified oncology pharmacist, Dr. Harvey serves as vice president of clinical research and executive director of Woodruff Industry Sponsored Clinical Trials at the Woodruff Health Sciences Center.

Dr. Harvey previously served as director of Winship Cancer Institute's Phase I Clinical Trials Unit and played a key role in the unit's opening in 2009 and subsequent expansion in 2018. He also served as medical director of Winship's Clinical Trials Office, where he worked to ensure the quality and compliance of clinical research practices at all Winship locations.

Dr. Harvey is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He is a Fellow of the American College of Clinical Pharmacy, a Fellow of the Hematology/Oncology Pharmacy Association and a Fellow of the American Society of Clinical Oncology.

Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes. An active principal and co-investigator on multiple trials, he also consults on experimental design of preclinical and clinical studies with a focus on optimizing correlative measures. Specific areas of research interest include agent tolerability and disposition in renal and hepatic impairment, effects of novel immunotherapeutics on hepatic metabolism, and use of therapeutic drug monitoring for anticancer agents.

Dr. Harvey is also active nationally and internationally in several cancer and pharmacology professional organizations. He is also a past president of the Hematology and Oncology Pharmacy Association, an international professional organization.

Education

Dr. Harvey obtained his BS Pharmacy and Doctor of Pharmacy degrees at the University of North Carolina at Chapel Hill (UNC).  He completed subsequent training at the University of Kentucky Medical Center and School of Pharmacy and specialized in Hematology/Oncology at UNC, where he was on staff and faculty for 8 years prior to coming to Grady Hospital in Atlanta where he served as a clinical specialist in hematology and oncology and director of the hematology and oncology residency program.

Research

Dr. Harvey's research interests include the clinical application of pharmacokinetic, pharmacodynamic, and pharmacogenomic data to patient care.

  • Below is a listing of current federal grants for the above principal investigator.

    GrantNumberTitle

Publications

Dr. Harvey is widely published in peer-reviewed journals. 

  • PublicationsPublication Date

Awards

Select awards and honors for Dr. Harvey include:

  • Award of Excellence, Hematology/Oncology Pharmacy Association (HOPA), 2018
  • James R. Eckman Award for Teaching Excellence, Emory School of Medicine Hematology and Medical Oncology Fellowship Program, 2014

Additional Websites

Cascade Link   TOP